These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Chromatographic characterization of neuropeptides in post mortem human brain. Biggins JA; McDermott JR; Smith AI; Candy JM; Perry RH; Bateman DE; Edwardson JA J Neurol Sci; 1984 Oct; 66(1):47-58. PubMed ID: 6084049 [TBL] [Abstract][Full Text] [Related]
4. Neurotensin in human brain: regional distribution and effects of neurological illness. Emson PC; Horsfield PM; Goedert M; Rossor MN; Hawkes CH Brain Res; 1985 Nov; 347(2):239-44. PubMed ID: 2933123 [TBL] [Abstract][Full Text] [Related]
5. Human brain distribution of neurotensin in normals, schizophrenics, and Huntington's choreics. Manberg PJ; Nemeroff CB; Iversen LL; Rosser MN; Kizer JS; Prange AJ Ann N Y Acad Sci; 1982; 400():354-67. PubMed ID: 6220630 [No Abstract] [Full Text] [Related]
6. A survey of substance P, somatostatin, and neurotensin levels in aging in the rat and human central nervous system. Buck SH; Deshmukh PP; Burks TF; Yamamura HI Neurobiol Aging; 1981; 2(4):257-64. PubMed ID: 6174878 [TBL] [Abstract][Full Text] [Related]
7. Reduction of cerebrospinal fluid glutamic acid in Huntington's chorea and in schizophrenic patients. Kim JS; Kornhuber HH; Holzmüller B; Schmid-Burgk W; Mergner T; Krzepinski G Arch Psychiatr Nervenkr (1970); 1980; 228(1):7-10. PubMed ID: 6104477 [TBL] [Abstract][Full Text] [Related]
8. Neuropeptides in the amygdala of controls, schizophrenics and patients suffering from Huntington's chorea: an immunohistochemical study. Zech M; Roberts GW; Bogerts B; Crow TJ; Polak JM Acta Neuropathol; 1986; 71(3-4):259-66. PubMed ID: 2948368 [TBL] [Abstract][Full Text] [Related]
9. Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease. Dawbarn D; De Quidt ME; Emson PC Brain Res; 1985 Aug; 340(2):251-60. PubMed ID: 2862959 [TBL] [Abstract][Full Text] [Related]
10. Implications of neuropeptides in neurological diseases. Sagar SM; Beal MF; Marshall PE; Landis DM; Martin JB Peptides; 1984; 5 Suppl 1():255-62. PubMed ID: 6207511 [TBL] [Abstract][Full Text] [Related]
14. Peptides, the limbic lobe and schizophrenia. Roberts GW; Ferrier IN; Lee Y; Crow TJ; Johnstone EC; Owens DG; Bacarese-Hamilton AJ; McGregor G; O'Shaughnessey D; Polak JM Brain Res; 1983 Dec; 288(1-2):199-211. PubMed ID: 6198024 [TBL] [Abstract][Full Text] [Related]
15. [Involvements of neuropeptides in pentylenetetrazol-induced convulsion in rats and effects of TRH and ceruletide on the convulsion]. Hashiguchi S; Masuda T; Fujimoto H; Kawai H; Saito S No To Shinkei; 1990 Jan; 42(1):73-8. PubMed ID: 1970933 [TBL] [Abstract][Full Text] [Related]
16. Neurotensin-like and somatostatin-like immunoreactivity within amacrine cells of the retina. Brecha N; Karten HJ; Schenker C Neuroscience; 1981; 6(7):1329-40. PubMed ID: 6115333 [No Abstract] [Full Text] [Related]
17. Involvement of non-opioid peptides in the pathogenesis of neurological and psychiatric disorders: evidence from CSF and post-mortem studies. Nemeroff CB; Bissette G Prog Clin Biol Res; 1985; 192():333-41. PubMed ID: 2934745 [TBL] [Abstract][Full Text] [Related]
18. Distribution of substance P, somatostatin and neurotensin in the human hypothalamus. Langevin H; Emson PC Brain Res; 1982 Aug; 246(1):65-9. PubMed ID: 6181851 [TBL] [Abstract][Full Text] [Related]
19. [Brain and intestinal peptides and endocrinological tests]. Oshima I Rinsho Byori; 1984 Jan; Spec No 58():62-77. PubMed ID: 6206257 [No Abstract] [Full Text] [Related]
20. Post mortem levels of thyrotropin-releasing hormone and neurotensin in the amygdala in Alzheimer's disease, schizophrenia and depression. Biggins JA; Perry EK; McDermott JR; Smith AI; Perry RH; Edwardson JA J Neurol Sci; 1983 Jan; 58(1):117-22. PubMed ID: 6405015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]